Treatment Avenues for Type 2 Diabetes and Current Perspectives on Adipokines

Author(s): Sayantani Pramanik, Nirali Rathwa, Roma Patel, A.V. Ramachandran, Rasheedunnisa Begum*.

Journal Name: Current Diabetes Reviews

Volume 14 , Issue 3 , 2018

Become EABM
Become Reviewer


Background: Diabetes has turned into a pandemic disorder that is affecting millions of people worldwide. Industries are aggressively racing and pursuing research towards the discovery of antidiabetic drug and the current global sale of such drugs are ever on the increase. However, in spite of such massive level of expenditure thereof, WHO projects that by 2030, diabetes will rank as the 7th leading cause of mortality.

Objective: It is in this context that we have reviewed here the various approaches available and possible towards diabetes management. This review also includes the WHO guidelines for controlling the glycemic levels, which must be known and followed by clinicians for a better diabetes management.

Conclusion: Despite having a wealth of FDA-approved therapeutic options for type 2 diabetes majorities of the patients are not able to achieve the appropriate glycemic control due to various factors. The development of new options with actions at multiple foci of diabetic manifestation and better efficacy may potentially help in improving the current scenario of T2D management.

Keywords: Type 2 diabetes, therapeutics, gut and brain derived molecules, adipokines, small molecule drugs, phytochemicals.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Page: [201 - 221]
Pages: 21
DOI: 10.2174/1573399813666170112142837
Price: $58

Article Metrics

PDF: 29
PRC: 1